Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytokine release (anti-inflammatory effect) refers to the secretion of anti-inflammatory cytokines, soluble proteins that suppress or resolve inflammatory responses. These cytokines inhibit the production and activity of pro-inflammatory cytokines, upregulate endogenous anti-cytokines, downregulate pro-inflammatory cytokine receptors, and suppress antigen presentation and T cell activation. Key anti-inflammatory cytokines include IL-10, IL-1Ra, IL-4, IL-6 (context-dependent), IL-11, and IL-13. They are produced by monocytes, macrophages, dendritic cells, and certain T lymphocyte subsets. A balanced interplay between pro- and anti-inflammatory cytokines is essential for health, and therapeutic enhancement of anti-inflammatory cytokine activity is being explored for various conditions.
Inhibition of pro-inflammatory cytokine production/activity, upregulation of endogenous anti-cytokines, downregulation of pro-inflammatory cytokine receptors, suppression of antigen presentation and T cell activation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytokine Release (Anti-Inflammatory Effect).